These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9094456)

  • 21. Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.
    Lewis DJ; Duvic M
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28338261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
    Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
    Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma.
    Boehncke WH; König K; Rück A; Kaufmann R; Sterry W
    Acta Derm Venereol; 1994 May; 74(3):201-5. PubMed ID: 7915462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.
    Rubio-Muniz CA; Sánchez-Velázquez A; Arroyo-Andrés J; Agud-de Dios M; Tarín-Vicente EJ; Falkenhain-López D; Ortiz-Romero PL
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e102-e105. PubMed ID: 37611255
    [No Abstract]   [Full Text] [Related]  

  • 25. Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy.
    Macheiner W; Jantschitsch C; Graninger W; Pálóczy K; Bálint G; Marschalkó M; Kainberger F; Breier F; Knobler RM
    J Am Acad Dermatol; 2003 Feb; 48(2):220-6. PubMed ID: 12582392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemotherapy for mycosis fungoides: a clinical and histological study.
    Lowe NJ; Cripps DJ; Dufton PA; Vickers CF
    Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine in the treatment of cutaneous T cell lymphoma.
    Street ML; Muller SA; Pittelkow MR
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1084-9. PubMed ID: 2273106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.
    Klein RS; Dunlop JD; Samimi SS; Morrissey KA; Evans KG; Gardner JM; Introcaso CE; Vittorio CC; Rook AH; Micaily B; Kim EJ
    J Am Acad Dermatol; 2013 Jun; 68(6):972-7. PubMed ID: 23415461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
    Aires D; Abhyankar S
    Hematol Oncol; 2023 Dec; 41(5):809-816. PubMed ID: 37974524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment.
    Fujii K; Yoshizaki A; Matsuoka A; Baba N; Ohshima K; Kanekura T
    Eur J Dermatol; 2024 Jun; 34(3):294-296. PubMed ID: 39015963
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
    Sanli H; Akay BN; Anadolu R; Ozcan M; Saral S; Akyol A
    J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
    Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
    Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State of the art therapy of mycosis fungoides and Sézary syndrome.
    Kemme DJ; Bunn PA
    Oncology (Williston Park); 1992 Feb; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
    Tsirigotis P; Pappa V; Papageorgiou S; Kapsimali V; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Stavrianeas N; Economopoulos T; Dervenoulas J
    Br J Dermatol; 2007 Jun; 156(6):1379-81. PubMed ID: 17459033
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
    Kim YH; Tavallaee M; Sundram U; Salva KA; Wood GS; Li S; Rozati S; Nagpal S; Krathen M; Reddy S; Hoppe RT; Nguyen-Lin A; Weng WK; Armstrong R; Pulitzer M; Advani RH; Horwitz SM
    J Clin Oncol; 2015 Nov; 33(32):3750-8. PubMed ID: 26195720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
    Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
    Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.